noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Cartesian Therapeutics Inc.

Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Aspira Women's Health Inc.

Statement of Changes in Beneficial Ownership - Form 4
Evergy Inc.

Evergy Appoints W. Bryan Buckler Executive Vice President and Chief[...]

Healthcare

Results

Regeneron Pharmaceuticals Inc.

08/26/2024 | Press release | Distributed by Public on 08/26/2024 05:29

Ordspono™ (odronextamab) Approved in the European Union for the Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Regeneron Pharmaceuticals Inc. | News | Health | Science | Research | Company News | Business Announcement | Products and Services | Securities Issuers | Biotechnology and Medical Research Companies | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | Bolsa Institucional de Valores (BIVA) | Hannover Stock Exchange | Nasdaq BX | Nasdaq PSX | NYSE Chicago

Back

Download the original document